Cationic CaMKII Inhibiting Nanoparticles Prevent Allergic Asthma.

about

Functional role of kynurenine and aryl hydrocarbon receptor axis in chronic rhinosinusitis with nasal polyps.

P2860

Q47839231-B2832241-CF8F-46BC-A634-09F1FD49EDCD

P2860

Cationic CaMKII Inhibiting Nanoparticles Prevent Allergic Asthma.

Item

http://www.wikidata.org/entity/Q46373828

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Cationic CaMKII Inhibiting Nanoparticles Prevent Allergic Asthma.

@en

Cationic CaMKII Inhibiting Nanoparticles Prevent Allergic Asthma.

@nl

type

Item

label

Cationic CaMKII Inhibiting Nanoparticles Prevent Allergic Asthma.

@en

Cationic CaMKII Inhibiting Nanoparticles Prevent Allergic Asthma.

@nl

prefLabel

Cationic CaMKII Inhibiting Nanoparticles Prevent Allergic Asthma.

@en

Cationic CaMKII Inhibiting Nanoparticles Prevent Allergic Asthma.

@nl

P1476

Cationic CaMKII Inhibiting Nanoparticles Prevent Allergic Asthma.

@en

P2093

Angie S Morris

http://www.w3.org/2001/XMLSchema#string

John D Paschke

http://www.w3.org/2001/XMLSchema#string

Mark E Anderson

http://www.w3.org/2001/XMLSchema#string

Sara C Sebag

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of a calmodulin kinase II inhibitor protein in brain

Th2 cytokines and asthma. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists.

Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats

Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines

CaMKII oxidative activation and the pathogenesis of cardiac disease

Eotaxin and the attraction of eosinophils to the asthmatic lung

Chitosan coating of copper nanoparticles reduces in vitro toxicity and increases inflammation in the lung

Toxicity of Nanoparticles and an Overview of Current Experimental Models

Identification of a cooperative mechanism involving interleukin-13 and eotaxin-2 in experimental allergic lung inflammation

Passage of inhaled particles into the blood circulation in humans

P304

2166-2175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACS.MOLPHARMACEUT.7B00114

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Aliasger Salem

Amaraporn Wongrakpanich

Isabella M Grumbach

Kareem Ebeid

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28460526

http://www.w3.org/2001/XMLSchema#string

P921

asthma

nanoparticle

P932

5800301

http://www.w3.org/2001/XMLSchema#string

Cationic CaMKII Inhibiting Nanoparticles Prevent Allergic Asthma.

about

P2860

P2860

Cationic CaMKII Inhibiting Nanoparticles Prevent Allergic Asthma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932